Future Medicine Ltd., part of Future Science Group, UK, has announced the launch of Diabetes Management - a new bimonthly title presenting findings, analyses and commentaries on the battle with Type 1 and Type 2 diabetes. The journal will be published by Future Medicine Ltd (UK, London), known for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.
Articles published in Diabetes Management address improvements in current therapeutics and patient compliance, together with perspectives on future prospects. The journal will discuss the impact of encouraging healthier lifestyles to reduce the risk of Type 2 diabetes and the importance of education in this context, with respect to symptoms. It will seek to provide clinicians and health workers with the latest findings and opinions on the optimum therapies for reducing the disabling effects of uncontrolled diabetes.
Four Associate Editors are in charge of the editorial direction of Diabetes Management. They will be supported by a team of international experts making up the editorial advisory board.
In a related announcement, Future Medicine Ltd also announced the launch of Pain Management - a new bimonthly title that will present findings, analysis and commentary on the battle with acute and chronic pain. The journal will seek to provide guidance to the multidisciplinary pain management community regarding the most effective pain strategies.
Search for more Diabetes related Medical Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
